Cargando…
Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial
PURPOSE: The International Union Against Cancer highlighted tumor budding as a tumor-related prognostic factor. International assessment criteria for tumor budding were recently defined by the 2016 International Tumor Budding Consensus Conference (ITBCC2016). This study aimed to clarify the prognost...
Autores principales: | Ueno, Hideki, Ishiguro, Megumi, Nakatani, Eiji, Ishikawa, Toshiaki, Uetake, Hiroyuki, Matsuda, Chu, Nakamoto, Yoshihiko, Kotake, Masanori, Kurachi, Kiyotaka, Egawa, Tomohisa, Yasumasa, Keigo, Murata, Kohei, Ikawa, Osamu, Shinji, Seiichi, Murotani, Kenta, Matsui, Shigeyuki, Teramukai, Satoshi, Tomita, Naohiro, Sugihara, Kenichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6675595/ https://www.ncbi.nlm.nih.gov/pubmed/31180819 http://dx.doi.org/10.1200/JCO.18.02059 |
Ejemplares similares
-
Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
por: Ishiguro, Megumi, et al.
Publicado: (2012) -
Optimal Criteria for G3 (Poorly Differentiated) Stage II Colon Cancer: Prospective Validation in a Randomized Controlled Study (SACURA Trial)
por: Ueno, Hideki, et al.
Publicado: (2020) -
Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial)
por: Ueno, Hideki, et al.
Publicado: (2021) -
Study protocol of the B-CAST study: a multicenter, prospective cohort study investigating the tumor biomarkers in adjuvant chemotherapy for stage III colon cancer
por: Ishiguro, Megumi, et al.
Publicado: (2013) -
Updated 5-year survival and exploratory T x N subset analyses of ACTS-CC trial: a randomised controlled trial of S-1 versus tegafur-uracil/leucovorin as adjuvant chemotherapy for stage III colon cancer
por: Kusumoto, Tetsuya, et al.
Publicado: (2018)